Cargando…
The role of kidney injury biomarkers in COVID-19
The coronavirus disease-2019 (COVID-19) outbreak has been declared a global pandemic. COVID-19-associated acute kidney injury (COVID-19 AKI) is related to a high mortality rate and serves as an independent risk factor for hospital death in patients with COVID-19. Early diagnosis would allow for earl...
Autores principales: | Su, Lianjiu, Zhang, Jiahao, Peng, Zhiyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359166/ https://www.ncbi.nlm.nih.gov/pubmed/35930243 http://dx.doi.org/10.1080/0886022X.2022.2107544 |
Ejemplares similares
-
A long journey for acute kidney injury biomarkers
por: Oh, Dong-Jin
Publicado: (2020) -
Mitochondria ROS and mitophagy in acute kidney injury
por: Su, Lianjiu, et al.
Publicado: (2022) -
Risk factors for acute kidney injury in COVID-19 patients: an updated systematic review and meta-analysis
por: Zhang, Jialing, et al.
Publicado: (2023) -
Acute toxic kidney injury
por: Petejova, Nadezda, et al.
Publicado: (2019) -
Biomarker for early renal microvascular and diabetic kidney diseases
por: Futrakul, Narisa, et al.
Publicado: (2017)